• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

IPO launch in Q3 2022 ---------top source confirmed


<



















Who cares about the IPO? It will impact less than 10% of our employees. Do you think the average Rep gives a dam about whether or not we go IPO? We just want to get our commision.
 




Similar threads

Replies
22
Views
4K
Replies
7
Views
2K
Replies
34
Views
7K
Galderma
anonymous
Replies
52
Views
11K